Brief: Medivir Strengthens Business Development Potential Of Remetinostat Through Renegotiated Multi-Party Agreement
16/08/2021 07:35
Aug 16 (Reuters) - Medivir AB MVIRb.ST :
* MEDIVIR STRENGTHENS THE BUSINESS DEVELOPMENT POTENTIAL OF
REMETINOSTAT THROUGH RENEGOTIATED MULTI-PARTY AGREEMENT
* PURPOSE OF NEW AGREEMENT IS TO CREATE IMPROVED BUSINESS
DEVELOPMENT OPPORTUNITIES.
* TOGETHER WITH ORIGINATORS OF REMETINOSTAT, AND TETRALOGIC
PHARMACEUTICALS CORPORATION AND LEUKEMIA & LYMPHOMA SOCIETY ("
STAKEHOLDERS") HAVE RESTRUCTURED AND STREAMLINED FINANCIAL
OBLIGATIONS FOR REMETINOSTAT
Source text for Eikon: ID:nWkr1xwVmB
Further company coverage: MVIRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))